NewswireToday - /newswire/ -
Wayne, PA, United States, 2006/08/02 - Octagon Research Solutions, Inc., announced today that the company has executed an agreement with Wyeth Pharmaceuticals to begin using ViewPoint®, Octagon’s Enterprise Submission Process Management Solution..
Octagon Research Solutions, Inc., a pioneer and leader in the electronic transformation of clinical R&D to the life sciences industry, announced today that the company has executed an agreement with Wyeth Pharmaceuticals, a division of Wyeth [NYSE:WYE}, one of the world’s largest research-driven pharmaceutical and health care products companies, to begin using ViewPoint®, Octagon’s Enterprise Submission Process Management Solution, for managing complex, cross-functional processes in support of regulatory submissions.
Jim Walker, chairman and CEO of Octagon stated, “We are pleased and honored that our ViewPoint product is going to be used by Wyeth Pharmaceuticals. Wyeth has always been a forward thinking and progressive company and the fact that they chose Viewpoint to help with their processes makes us very proud as a company. I am looking forward to building upon this relationship.”
Octagon’s ViewPoint® facilitates communication, planning and management of complex processes. It provides real-time metrics, reporting and search capabilities to answer process questions. ViewPoint also enables users to manage content, resources, tasks and issues across the entire submission lifecycle.
In Wyeth’s case, ViewPoint will enable Wyeth’s Global Regulatory Affairs (GRA) to effectively communicate within and across project teams and departments regarding project information, provide visibility across business units on related projects and activities, track and manage a variety of regulatory projects and processes, and use ViewPoint’s Regulatory Dashboard to provide GRA real-time, daily views of information for all projects and processes. At Wyeth, 22 Regulatory business processes have been documented and configured within ViewPoint and 30+ training sessions are to be administered by Octagon professionals over the coming weeks.
ViewPoint will also support GRA’s process for tracking and managing workload and resources. Using an accurate content plan with the associated task benchmarks, the GRA team can use ViewPoint’s Project Estimator tool to project resources and workload required to complete the project.
During the course of executing the project and processes, ViewPoint will be capturing data to enable GRA to produce and report on metrics as well as to track regulatory and submission management activities. In addition, ViewPoint will provide reports that support GRA in getting project status information as well as compiling real-time metrics during the wrap-up of the submission project.
Kirk Gallion, Octagon’s president added, “Gina Schmidt, assistant vice president, Global Regulatory Submissions Management, Global Regulatory Affairs, and her entire Global Regulatory Affairs team at Wyeth have a vision to become the industry leader in effectively managing submission processes. I believe they are positioned for success as they use ViewPoint to initiate, manage, and report on all submission processes from original marketing applications to their daily maintenance submissions.”
About Octagon Research Solutions, Inc.
Octagon is a pioneer and leading process-centric solutions provider that offers a suite of regulatory, clinical, process and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. We leverage the power of electronic submissions through cross-functional eSub expertise, a holistic process approach, deep domain knowledge and integrated solutions. Octagon is headquartered in Wayne, PA, with offices in Boston, MA, Costa Mesa, CA, and European headquarters in Amersham, UK.